ProShare Advisors’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,721
| Closed | -$21K | – | 2175 |
|
|
2022
Q1 | $21K | Sell |
1,721
-409
| -19% | -$4.99K | ﹤0.01% | 2173 |
|
|
2021
Q4 | $69K | Buy |
2,130
+69
| +3% | +$2.24K | ﹤0.01% | 2246 |
|
|
2021
Q3 | $92K | Sell |
2,061
-544
| -21% | -$24.3K | ﹤0.01% | 1921 |
|
|
2021
Q2 | $142K | Buy |
2,605
+493
| +23% | +$26.9K | ﹤0.01% | 2230 |
|
|
2021
Q1 | $158K | Buy |
2,112
+485
| +30% | +$36.3K | ﹤0.01% | 2094 |
|
|
2020
Q4 | $176K | Buy |
1,627
+381
| +31% | +$41.2K | ﹤0.01% | 1883 |
|
|
2020
Q3 | $110K | Sell |
1,246
-49
| -4% | -$4.33K | ﹤0.01% | 1516 |
|
|
2020
Q2 | $138K | Buy |
+1,295
| New | +$138K | ﹤0.01% | 1530 |
|
|
2020
Q1 | – | Sell |
-1,388
| Closed | -$96K | – | 1632 |
|
|
2019
Q4 | $96K | Sell |
1,388
-156
| -10% | -$10.8K | ﹤0.01% | 1695 |
|
|
2019
Q3 | $160K | Buy |
1,544
+38
| +3% | +$3.94K | ﹤0.01% | 1481 |
|
|
2019
Q2 | $139K | Buy |
1,506
+88
| +6% | +$8.12K | ﹤0.01% | 1499 |
|
|
2019
Q1 | $130K | Buy |
1,418
+11
| +0.8% | +$1.01K | ﹤0.01% | 1544 |
|
|
2018
Q4 | $78K | Buy |
+1,407
| New | +$78K | ﹤0.01% | 1501 |
|